Article

Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs

2020-04-24

Abstract excerpt

<h4>ABSTRACT</h4> The risk-benefit ratio associated with the use of repurposed drugs to treat 2019 SARS-CoV-2 related infectious disease (COVID-19) is complicated since benefits are awaited, not proven. A thorough literature search was conducted to source information on the pharmacological properties of 5 drugs and 1 combination (azithromycin, chloroquine, favipiravir, hydroxychloroquine, remdesivir, and lopinavir...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fc89d359-490b-5cd6-b348-e50674a96227
DOI: 10.1101/2020.04.21.20066761

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugsDOI 10.1101/2020.04.21.20066761Read

Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.Semantic proximity Read

Computational Determination of Toxicity Risks Associated with a Selection of Approved Drugs having Demonstrated Activity Against COVID- 19Semantic proximity Read

Molecular predictors of drug-induced prolongation of the QT interval.Semantic proximity Read

Comprehensive preclinical evaluation of how cardiac safety profiles of potential COVID-19 drugs are modified by disease associated factors.Semantic proximity Read

Hydroxychloroquine and azithromycin: As a double edge sword for COVID-19?Semantic proximity Read

Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical SettingsSemantic proximity Read

Drug‐ and non‐drug‐associated QT interval prolongationSemantic proximity Read

Drug-induced torsades de pointes: the evolving role of pharmacogenetics.Semantic proximity Read

Genetic and Molecular Aspects of Drug-Induced QT Interval ProlongationSemantic proximity Read

Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World PracticeSemantic proximity Read

QT interval prolongation and cardiac risk assessment for novel drugs.Semantic proximity Read

Cardiovascular drugs inducing QT prolongation: facts and evidence.Semantic proximity Read